Showing results (31-40 of 57) with videos related to
Sort By:
Pageof 6
BMJ Open|June 12, 2024
Graves-PCD: protocol for a randomised, dose-finding, adaptive trial of the plasma cell-depleting agent daratumumab in severe Graves' diseaseFaye Wolstenhulme, Irena Bibby, Michael Cole, et al.Central European Journal of Urology|September 5, 2019
The industrial revolution for the management of benign prostate obstruction: worldwide publication trends for surgical and medical therapies over the past two decadesJeremy Nettleton, Patrick Jones, Amelia Pietropaolo, et al.Journal of Clinical Medicine|January 11, 2024
Role of Renal Biopsy in the Management of Renal Cancer: Concordance between Ultrasound/CT-Guided Biopsy Results and Definitive Pathology, Adverse Events, and Complication RateGianmarco Isgrò, Alistair Rogers, Rajan Veeratterapillay, et al.Neurourology and Urodynamics|February 20, 2019
International Continence Society consensus on the diagnosis and treatment of nocturiaKarel Everaert, Francois Hervé, Ruud Bosch, et al.Neurourology and Urodynamics|December 9, 2025
Phenotyping Overactive Bladder-Part 1: Are There Different Types of Urgency and Can They be Translated to Clinical, Urodynamic and Radiological Phenotyping? ICI-RS 2025John E Speich, D Carolina Ochoa, Pradeep Tyagi, et al.Journal of Clinical Urology|August 24, 2023
Re-evaluating the diagnostic efficacy of PSA as a referral test to detect clinically significant prostate cancer in contemporary MRI-based image-guided biopsy pathwaysArtitaya Lophatananon, Alexander Light, Nicholas Burns-Cox, et al.Neurourology and Urodynamics|December 11, 2019
Is the value of urodynamics undermined by poor technique?: ICI-RS 2018Andrew Gammie, Fernando Almeida, Marcus Drake, et al.BJU International|November 2, 2021
Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort studyRajan Veeratterapillay, Robert Geraghty, Rajadoss Pandian, et al.British Journal of Cancer|January 20, 2024
Results of a randomised Phase II trial of olaparib, chemotherapy or olaparib and cediranib in patients with platinum-resistant ovarian cancerShibani Nicum, Naomi McGregor, Rachel Austin, et al.BJU International|June 20, 2020
The cost-effectiveness of transurethral resection of the prostate vs thulium laser transurethral vaporesection of the prostate in the UNBLOCS randomised controlled trial for benign prostatic obstructionSian M Noble, Aideen M Ahern, Jo Worthington, et al.Pageof 6